Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
3.12M
-
Number of holders
-
65
-
Total 13F shares, excl. options
-
26.8M
-
Shares change
-
+813K
-
Total reported value, excl. options
-
$732M
-
Value change
-
+$35.9M
-
Number of buys
-
41
-
Number of sells
-
-24
-
Price
-
$27.33
Significant Holders of Passage BIO, Inc. - COMMON STOCK (PASG) as of Q2 2020
76 filings reported holding PASG - Passage BIO, Inc. - COMMON STOCK as of Q2 2020.
Passage BIO, Inc. - COMMON STOCK (PASG) has 65 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26.8M shares
.
Largest 10 shareholders include ORBIMED ADVISORS LLC (6.96M shares), FRAZIER MANAGEMENT LLC (5.01M shares), New Leaf Venture Partners, L.L.C. (2.5M shares), Vivo Capital, LLC (2.23M shares), BOXER CAPITAL, LLC (1.93M shares), BlackRock Inc. (1.41M shares), HIGHLINE CAPITAL MANAGEMENT, L.P. (648K shares), VANGUARD GROUP INC (527K shares), ALKEON CAPITAL MANAGEMENT LLC (505K shares), and MORGAN STANLEY (392K shares).
This table shows the top 65 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.